Birdwatch Note Rating
2023-03-15 20:29:36 UTC - HELPFUL
Rated by Participant: D8798B311876CD8492360DC4B6735173875FECEDB88B2966B55462E5A8463EFD
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details